Oxford BioDynamics Bartu Ahiska on breakthrough CFS test
…
0,008€
66,67%
Echtzeit-Aktienkurs Oxford BioDynamics PLC
Bid:
Ask:
Nachrichten zur Oxford BioDynamics PLC Aktie
Oxford BioDynamics shares soar 33% after unveiling breakthrough blood test for Chronic Fatigue Syndrome
Oxford BioDynamics PLC (AIM:OBD, OTC:OXBOF) shares surged 33% on Wednesday after the company announced it had developed a highly accurate…
Oxford BioDynamics unveils blood test for Chronic Fatigue Syndrome with 96% accuracy
Oxford BioDynamics PLC (AIM:OBD, OTC:OXBOF) has developed what it calls a “first-in-class” blood test to diagnose Chronic Fatigue Syndrome, a…
AIM weekly movers: Oxford BioDynamics gains recognition from Pfizer trial
Oil and gas producer Empyrean Energy (LON: EME) says the operator of the Mako field has signed a gas sales…
AIM movers: Pfizer confirms efficacy of Oxford BioDynamics EpiSwitch and Sosandar write down reduces profit
Oxford BioDynamics (LON: OBD) says Pfizer has published information on its use of EpiSwitch biomarkers as a liquid biopsy in…
AIM movers: Hornby leaving AIM and ex-dividends
Ethernity Networks (LON: ENET) has invoiced $890,000 of a $1.05m contract with a US aerospace system products provider. The contract…